Nicola Fusco, Director of Biobank for Translational and Digital Medicine Unit, Laboratory of Pathological Anatomy (Histology and NGS Molecular Diagnostics), and Division of Pathology at IEO European Institute of Oncology, shared a post on LinkedIn:
“Just back from the European Congress of Pathology 2025 in Vienna, an event that marked a before and after for our community.
For the first time, I saw pathologists aligned on the clinically crucial priorities: accurate diagnosis, quality, sustainability, molecular testing, and artificial intelligence.
I am proud that the IEO European Institute of Oncology was among the key players in this congress, thanks to Elena Guerini Rocco and Konstantinos Venetis.
This is pathology now, and it is digital, molecular, and AI-powered.”
More posts featuring Nicola Fusco.
